WHO Launches Multi-Country Coronavirus Treatment Study As Global Case Count Passes 200K

CIDRAP News: Global COVID-19 total tops 200,000; WHO unveils massive treatment study
“With outbreaks gaining steam in many countries, the global COVID-19 total passed 200,000 reported cases [Wednesday], and the World Health Organization (WHO) announced a large international clinical trial to test five treatment regimens. … Regarding the trial, [WHO Director-General] Tedros said multiple small trials using different methods may not yield strong evidence needed to reveal which ones can save lives. So he said the WHO has organized a large international study — called the SOLIDARITY trial — to get more robust data. He said the simplified study design allows even overloaded hospitals to participate. So far, countries that have agreed to participate include Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland, and Thailand…” (Schnirring, 3/18).

Additional coverage of experimental treatments for SARS-CoV-2 and the disease’s spread is available from Newsweek, New York Times, STAT, and U.N. News.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.